NOVEMBER 9, 2020

FDA Expands Neuromodulation Device Indication to Chronic Migraine

The FDA expanded the indication of the remote electrical neuromodulation device Nerivio (Theranica) to include patients with chronic migraine.

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select